Chemomab Therapeutics Ltd.: which funds bought and sold
Institutions that bought and sold Chemomab Therapeutics shares in Q2 2026, from the holdings they reported to the SEC on Form 13F for March 31, 2026 and June 30, 2026.
Between March 31, 2026 and June 30, 2026, 5 institutions that filed 13F reports for both quarters added to or opened positions in Chemomab Therapeutics, and 7 cut or closed them. Together they added a net 28K shares, +8.0% on what they held at the start of the quarter. Active managers and hedge funds on our list were net buyers of 31K shares (+21.6%); index fund managers were net buyers of 12K shares (+66.2%). 1 opened a new position and 3 sold out entirely.
Bought, Q2 2026 5 institutions, 1 of them new holders Sold, Q2 2026 7 institutions, 3 of them sold out
Net change, all compared +28K shares (+8.0%)
Net change, active managers +31K shares (+21.6%), 1 bought, 0 sold
Buyers versus sellers
5 bought 4 7 sold
Active managers and hedge funds 1 bought · 0 sold · +31K
Index fund managers 1 bought · 0 sold · +12K
Other institutions 3 bought · 7 sold · −15K
Biggest buyers
| Institution | Change in shares | Shares June 30, 2026 | Value |
|---|---|---|---|
| Citadel Advisors LLC Hedge fund | +31K +48.5% | 95K | $154,404 |
| Lido Advisors, LLC | +14K New position | 14K | $23,232 |
| Rhumbline Advisers Index funds | +12K +66.2% | 31K | $49,457 |
| Philadelphia Investment Partners, LLC | +6,800 +82.9% | 15K | $24,300 |
| Sbi Securities Co., Ltd. | +6 +21.4% | 34 | $55 |
| Institution | Change in shares | Shares June 30, 2026 | Value |
|---|---|---|---|
| Citadel Advisors LLC Hedge fund | +31K +48.5% | 95K | $154,404 |
Biggest sellers
| Institution | Change in shares | Shares June 30, 2026 | Value |
|---|---|---|---|
| Smartharvest Portfolios, LLC | −15K Sold out | 0 | — |
| Susquehanna International Group, LLP | −13K Sold out | 0 | — |
| Gamma Investing LLC | −2,839 −37.5% | 4,740 | $7,679 |
| Xtx Topco Ltd | −2,642 −14.2% | 16K | $25,899 |
| BNP Paribas Financial Markets | −1,620 −19.2% | 6,805 | $11,024 |
| Morgan Stanley | −1,000 −21.9% | 3,575 | $5,792 |
| UBS Group AG | −8 Sold out | 0 | — |
| Institution | Change in shares | Shares June 30, 2026 | Value |
|---|---|---|---|
| None of the active managers on our list. | |||
New positions
| Institution | Shares | Value June 30, 2026 |
|---|---|---|
| Lido Advisors, LLC | 14K | $23,232 |
Sold out
| Institution | Shares | Value March 31, 2026 |
|---|---|---|
| Smartharvest Portfolios, LLC | 15K | $22,869 |
| Susquehanna International Group, LLP | 13K | $21,181 |
| UBS Group AG | 8 | $13 |
Who holds the shares
- Institutions reporting
- 13
- Ten largest holders
- 99.0% of 13F-reported shares
- Index fund managers
- 8.0% of 13F-reported shares
- Active managers and hedge funds
- 46.2% of 13F-reported shares
| Type | Bought | Sold | New | Sold out | Net change in shares | Net % |
|---|---|---|---|---|---|---|
| Active managers and hedge funds | 1 | 0 | 0 | 0 | +31K | +21.6% |
| Index fund managers | 1 | 0 | 0 | 0 | +12K | +66.2% |
| Other institutions | 3 | 7 | 1 | 3 | −15K | −8.0% |
← Back to Chemomab Therapeutics Ltd. · Insiders · Politicians